AI Verdict
IBTA has stronger fundamentals based on our AI analysis.
IBTA vs IBO Fundamental Comparison
| Metric | IBTA | IBO |
|---|---|---|
| Revenue | $342.4M | $32,000.0 |
| Net Income | $3.6M | $-11.8M |
| Net Margin | 1.0% | -36,993.8% |
| ROE | 1.2% | -93.9% |
| ROA | 0.7% | -68.0% |
| Current Ratio | 1.96x | 0.35x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $0.12 | $-0.38 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IBTA vs IBO: Frequently Asked Questions
Is IBTA or IBO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IBTA has stronger fundamentals. IBTA is rated HOLD (68% confidence) while IBO is rated STRONG SELL (95% confidence). This is not investment advice.
How does IBTA compare to IBO fundamentally?
Ibotta, Inc. has ROE of 1.2% vs IMPACT BIOMEDICAL INC.'s -93.9%. Net margins are 1.0% vs -36,993.8% respectively.
Which stock pays higher dividends, IBTA or IBO?
IBTA has a dividend yield of N/A or no dividend while IBO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IBTA or IBO for long term?
For long-term investing, consider that IBTA has HOLD rating with 68% confidence, while IBO has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IBTA vs IBO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IBTA vs IBO, the AI consensus favors IBTA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.